Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Arrhythmia Research Technology, Inc. Announces Proposed Asset Purchase.


Business Editors

FITCHBURG, Mass.--(BUSINESS WIRE)--June 3, 2002

Arrhythmia arrhythmia (ārĭth`mēə), disturbance in the rate or rhythm of the heartbeat. Various arrhythmias can be symptoms of serious heart disorders; however, they are usually of no medical significance except in the presence of  Research Technology, Inc. ("ART") (AMEX AMEX

See: American Stock Exchange
: HRT HRT
abbr.
hormone replacement therapy


Hormone replacement therapy (HRT)
Also called estrogen replacement therapy, this controversial treatment is used to relieve the discomforts of menopause.
) today announced that its wholly-owned subsidiary, Micron Acquisition Corp. has entered into a non-binding Letter of Intent to purchase certain operating assets Operating Assets

Another term for working capital.
 of Select Engineering, Inc. ("Select") of Fitchburg, Massachusetts, a privately-held company, for a purchase price (subject to adjustment based on Select's inventory at closing), of approximately $5,850,000. Select and ART's wholly-owned subsidiary, Micron Products, Inc., manufacture silver- and silver chloride- plated sensor elements for use in the manufacture of disposable electrodes for ECG ECG electrocardiogram.

ECG
abbr.
1. electrocardiogram

2. electrocardiograph


ECG
Also called an electrocardiogram, it records the electrical activity of the heart.
 diagnostic, monitoring and related instrumentation. Select is closely held A phrase used to describe the ownership, management, and operation of a corporation by a small group of people.

In a closely held corporation, the same people often act as shareholders, directors, and officers, and no outside investors exist.
 and reported unaudited sales of approximately $5,000,000 for its fiscal year ended December 31, 2001. The proposed transaction is subject to a number of contingencies, including the negotiation and execution of a mutually acceptable purchase agreement, arranging bank financing on terms acceptable to Micron Acquisition Corp. and completion of the due diligence review of the assets of Select to be purchased. If consummated, the purchase of Select's assets is expected to close on or about August 1, 2002

Forward looking statements made herein are based on current expectations of ART and involve a number of risks and uncertainties and should not be considered as guarantees of future performance. These statements are made under the Safe Harbor Provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. The factors that could cause actual results to differ materially include: interruptions or cancellations of existing contracts, impact of competitive products and pricing, product demand and market acceptance and risk, the presence of competitors with greater financial resources than ART, product development and commercialization risks and an inability to arrange additional debt or equity financing.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:Arrhythmia Research Technology, Inc. Announces Proposed Asset Purchase.
Publication:Business Wire
Geographic Code:1USA
Date:Jun 3, 2002
Words:285
Previous Article:Metrocall Files Voluntary Chapter 11 Petition; Cites Support of Primary Creditor Constituencies.
Next Article:Teamstudio Screensurfer Marries Mainframes to the Web;...Users Praise Agility of New Software Integration Tool...
Topics:



Related Articles
Heart drug trial cut short.
Arrhythmias/rhythm disorders.
NORTRAN DRUG EFFECTIVE IN ATRIAL ARRHYTHMIA MODEL.
MONDAY HEART-ATTACK RISK HIGH EVEN AMONG RETIRED.
Syncope and the runner.
"Heart rhythm" & "J. of the American College of Radiology".
Follow up ...
REIT sells $1.7b portfolio.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles